Febuxostat Impurity 25, identified by its CAS number 1643131-89-8, is a chemical compound that serves as an impurity associated with the pharmaceutical agent febuxostat, which is primarily used to treat gout by inhibiting xanthine oxidase. While specific characteristics of Febuxostat Impurity 25 may not be widely documented, impurities in pharmaceuticals typically exhibit properties such as varying solubility in different solvents, potential reactivity with other compounds, and distinct spectral characteristics in techniques like NMR or mass spectrometry. The presence of impurities can affect the efficacy and safety of the primary drug, making their characterization essential in pharmaceutical development. Regulatory guidelines often require detailed profiling of such impurities to ensure quality control and compliance with safety standards. Understanding the chemical structure, stability, and potential biological activity of impurities like Febuxostat Impurity 25 is crucial for assessing their impact on the overall formulation and therapeutic outcomes.

Febuxostat Impurity 25

1643131-89-8: Febuxostat Impurity 25, identified by its CAS number 1643131-89-8, is a chemical compound that serves as an impurity associated with the pharmaceutical agent febuxostat, which is primarily used to treat gout by inhibiting xanthine oxidase. While specific characteristics of Febuxostat Impurity 25 may not be widely documented, impurities in pharmaceuticals typically exhibit properties such as varying solubility in different solvents, potential reactivity with other compounds, and distinct spectral characteristics in techniques like NMR or mass spectrometry. The presence of impurities can affect the efficacy and safety of the primary drug, making their characterization essential in pharmaceutical development. Regulatory guidelines often require detailed profiling of such impurities to ensure quality control and compliance with safety standards. Understanding the chemical structure, stability, and potential biological activity of impurities like Febuxostat Impurity 25 is crucial for assessing their impact on the overall formulation and therapeutic outcomes.

CAS 1643131-89-8

Febuxostat Impurity 25

Febuxostat Amide Methyl Ester

Ref: ST-EA-CP-F7047